Rebecca Shatsky, MD, is a medical oncologist specializing in breast medical oncology and precision oncology. She is a Full Professor of Clinical Medicine at UC San Diego Health Sciences and serves as Breast Medical Oncology Team Leader at UC San Diego Health Moores Cancer Center, where she also directs the Breast Cancer Clinical Trials Program and leads disease-focused clinical programs within the cancer center and the Sanford Stem Cell Institute. Her clinical work centers on breast oncology, precision medicine and immunotherapy approaches, and the care of younger adults with cancer, with an emphasis on integrating advanced molecular profiling to individualize treatment decisions. Dr. Shatsky’s research interests include translational oncology, multi-omics–guided therapy development, and innovative immunotherapy and targeted-treatment strategies, including novel drug-delivery approaches. She holds national leadership roles as National Co-Chair for clinical trial operations for I-SPY2 and as a member of ASCO and NCCN guideline panels, and serves on the Scientific Advisory Board of the International Lobular Breast Cancer Alliance; her research program is supported by funding from organizations including the Breast Cancer Research Foundation, the California Initiative to Advance Precision Medicine, CureBound, the Alpha Clinic, and the National Cheers Foundation. She earned her MD from the Keck School of Medicine of USC, completed an Internal Medicine residency at UCLA, and pursued a breast cancer–focused Hematology/Oncology clinical and research fellowship at UC San Diego School of Medicine.
Professor
Medical School
2007 – 2011
Residency
2011 – 2014
Fellowship
2014 – 2017